Search
Peter Scardino, MD, has been named the new Chairman of the Department of Surgery at Memorial Sloan Kettering Cancer Center.
Learn how nurses at MSK also engage in cancer research projects designed to help improve patients’ treatment, symptoms, or experience.
Biologists at Memorial Sloan Kettering Cancer Center have identified a set of genes expressed in human breast cancer cells that work together to remodel the network of blood vessels at the site of the primary tumor.
Learn more about the link between drinking alcohol and the risk of developing cancer.
Memorial Sloan Kettering Cancer Center feted three gifted young investigators for their insightful contributions to cancer research in a public symposium on December 1, 2011.
Learn about MSK's new Program for Drug Development in Leukemia (PDD-L), which will offer more clinical trials for many types of leukemia.
Radiation therapy after surgery can sharply reduce the chance that certain low-risk breast cancers will return.
The US Food and Drug Administration announced today that the drug ipilimumab (brand name Yervoy) has been approved for the treatment of patients with metastatic melanoma. It is the first drug ever shown to improve overall survival for patients with advanced melanoma.
MSK researchers are leading the development of new artificial intelligence (AI) models to improve the targeting of radiation therapy — teaching computers to better isolate tumors and spare more of the surrounding healthy tissue.
During the pandemic, Dr. John Chodera’s lab shifted gears to help find new drugs against COVID-19. Learn how lessons from the effort are already aiding in the search for new cancer drugs.